目的分析自体外周血造血干细胞支持下高剂量化疗对于晚期乳腺癌化疗前后生活质量影响,为选择有效改善患者生活质量的干预措施提供依据。方法回顾性分析25例病例组行自体外周血造血干细胞支持下高剂量化疗的晚期乳腺癌患者临床资料,同期选取接受常规方案化疗的22例晚期乳腺癌患者为对照组。采用简明健康状况调查量表SF-36(MOS36-item short forum health survey)的缩减版本SF-12量表作为问卷调查表。在第1个时间点(T1)为治疗前,第2个时间点(T2)为第2周期高剂量化疗前和第4周期常规治疗前,第3个时间点(T3)为高剂量化疗结束3月随访时和常规剂量化疗结束后3月进行调查随访。采用t检验进行统计分析。结果高剂量化疗组和常规剂量组患者生活质量8个维度评分T2较T1均显著下降(P<0.05),T3较T1两组患者活力和社会功能维度仍显著下降(P<0.05),其他维度差异无统计学意义。T2时间点高剂量化疗组较常规剂量化疗组总体健康、生理功能、活力和社会功能维度显著下降(P<0.05),T1和T3时间点高剂量化疗组和常规剂量组差异无统计学意义。结论自体外周血造血干细胞支持下高剂量化疗导致乳腺癌患者总体...
【英文摘要】
Objective To analyze the quality of life(QOL) of advanced breast cancer patients after receiving high-dose chemotherapy supported by autologous peripheral blood stem cells, and to provide evidence for selecting the effective intervening measure to improve QOL of patients. Methods We retrospectively analyzed 25 advanced breast cancer patients who were treated with high-dose chemotherapy supported by autologous peripheral blood stem cells and 22 patients who received conventional-dose therapy as the control g...